| NDC Code | 65219-052-29 |
|---|
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-052-29) > 5 mL in 1 VIAL, SINGLE-DOSE (65219-052-09) |
|---|
| Product NDC | 65219-052 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Potassium Phosphates |
|---|
| Non-Proprietary Name | Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20200210 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA212832 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC |
|---|
| Strength | 236; 224 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC] |
|---|